BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

  Specialty cancer diagnostics company Precipio, Inc., announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year.

  February 13, 2024

   · 

  3 min read
• Business

  LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024

  LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market close.

  February 13, 2024

   · 

  1 min read
• Ajinomoto Co. Launches Silicon Valley CVC HQ to Grow U.S. Investments, Adds New Portfolios

  Ajinomoto Co., Inc., the Japan-based multinational corporation covering food, healthcare and electronic materials, and built on “AminoScience,” has expanded its corporate venture capital arm with new U.S. headquarters to grow its investments in U.S. and global companies.

  February 13, 2024

   · 

  2 min read
• PatenSee and Fresenius Medical Care Sign Clinical Collaboration Agreement

  PatenSee, developer of a fistula monitoring system for dialysis patients, has entered into an agreement with Fresenius Medical Care, a leading global provider of dialysis services.

  February 13, 2024

   · 

  2 min read
• BioForest

  ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline

  ProfoundBio announced an oversubscribed $112 million Series B financing supported by a syndicate of top healthcare dedicated and mutual fund institutional investors.

  February 13, 2024

   · 

  7 min read
• Genetown

  House Select Committee Tours Ginkgo Bioworks, Previews Biofab1, Ginkgo’s New Integrated Data Generation Facility Set to Launch in 2025

  Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, hosted members of Congress focused on strengthening the U.S. bioeconomy in service of national and economic security yesterday.

  February 13, 2024

   · 

  7 min read
• Business

  Nicoya Expands Into India With Appointment of Medispec as Exclusive Distributor

  Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technology, is pleased to announce the appointment of Medispec as its exclusive distributor in India.

  February 13, 2024

   · 

  2 min read
• BioMidwest

  Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System

  Accuray Incorporated (NASDAQ: ARAY) announced today that the team at Quebec’s Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is the first in Canada to treat cancer patients using the company’s Radixact® radiation therapy delivery system.

  February 13, 2024

   · 

  5 min read
• FDA

  CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma

  Candel Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for CAN-3110 -- a first-in-class, replication-competent herpes simplex virus-1 (HSV-1) oncolytic viral immunotherapy candidate.

  February 13, 2024

   · 

  8 min read
• Bio NC

  Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma

  Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma.

  February 13, 2024

   · 

  4 min read